BERT MARTIN GLASER
Medical Practice in Baltimore, MD
License number
Pennsylvania MD045385E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Baltimore, MD 21204
Pennsylvania
Pennsylvania
Personal information
See more information about BERT MARTIN GLASER at radaris.comName
Address
Phone
5111 Bradley Blvd, Chevy Chase, MD 20815
2020 Chesapeake Harbour Dr E, Annapolis, MD 21403
9050 Iron Horse Ln, Pikesville, MD 21208
901 Dulaney Valley Rd, Towson, MD 21204
5530 Wisconsin Ave, Chevy Chase, MD 20815
Professional information
See more information about BERT MARTIN GLASER at trustoria.com
Bert Glaser, Fredericksburg VA
Bert Glaser, Fredericksburg VA
Work:
The National Retina Institute
200 Executive Center Pkwy, Fredericksburg, VA 22401 The National Retina Institute
901 Dulaney Valley Rd, Towson, MD 21204 The National Retina Institute
5530 Wisconsin Ave, Chevy Chase, MD 20815 The National Retina Institute
8065 Leesburg Pike, Vienna, VA 22182 The National Retina Institute
9378 Forestwood Ln, Manassas, VA 20110 The National Retina Institute
18045 Georgia Ave, Olney, MD 20832 The National Retina Institute
8860 Columbia 100 Pkwy, Columbia, MD 21045 National Retina Institute
2946 Sleepy Hollow Rd, Falls Church, VA 22044 Eastpoint Office Park
1005 N Point Blvd, Baltimore, MD 21224 The National Retina Institute
1001 Pine Heights Ave, Baltimore, MD 21229 National Retina Institute
3402 Olandwood Ct, Olney, MD 20832 National Retina Institute
1400 Spring St, Silver Spring, MD 20910
200 Executive Center Pkwy, Fredericksburg, VA 22401 The National Retina Institute
901 Dulaney Valley Rd, Towson, MD 21204 The National Retina Institute
5530 Wisconsin Ave, Chevy Chase, MD 20815 The National Retina Institute
8065 Leesburg Pike, Vienna, VA 22182 The National Retina Institute
9378 Forestwood Ln, Manassas, VA 20110 The National Retina Institute
18045 Georgia Ave, Olney, MD 20832 The National Retina Institute
8860 Columbia 100 Pkwy, Columbia, MD 21045 National Retina Institute
2946 Sleepy Hollow Rd, Falls Church, VA 22044 Eastpoint Office Park
1005 N Point Blvd, Baltimore, MD 21224 The National Retina Institute
1001 Pine Heights Ave, Baltimore, MD 21229 National Retina Institute
3402 Olandwood Ct, Olney, MD 20832 National Retina Institute
1400 Spring St, Silver Spring, MD 20910
Bert M Glaser, Towson MD
Bert M Glaser, Towson MD
Specialties:
Ophthalmologist
Address:
901 Dulaney Valley Rd, Towson, MD 21204
8065 Leesburg Pike, Vienna, VA 22182
8065 Leesburg Pike, Vienna, VA 22182
Education:
Columbia University, College of Physicians and Surgeons - Doctor of Medicine
Johns Hopkins Hospital - Fellowship - Vitreoretinal
Johns Hopkins Hospital - Residency - Ophthalmology
Johns Hopkins Hospital - Fellowship - Vitreoretinal
Johns Hopkins Hospital - Residency - Ophthalmology
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology
Method And System For Using Simulation Techniques In Ophthalmic Surgery Training
Method And System For Using Simulation Techniques In Ophthalmic Surgery Training
US Patent:
2007020, Sep 6, 2007
Filed:
Mar 5, 2007
Appl. No.:
11/713669
Inventors:
Bert Glaser - Baltimore MD, US
Michael Grodin - Falls Church VA, US
Michael Grodin - Falls Church VA, US
International Classification:
G09B 23/28
US Classification:
434262
Abstract:
A method and system for enhanced ophthalmic surgery training by using simulation techniques. Each type of ophthalmic surgery, such as retinal or cataract surgery, is broken down into a sequence of surgical tasks, and each task is programmed into the system. A user practices each task via a simulator on a virtual human subject until a pre-determined level of skill is acquired for the task. The present invention objectively and effectively assesses a user's skill and expertise level in performing ophthalmic surgery via gated performance testing, thereby ensuring that the user has a pre-determined skill and expertise level, and eliminating undue risk to patients.
Owner, The National Retina Institute
Owner, The National Retina Institute
Position:
Owner at The National Retina Institute
Location:
Baltimore, Maryland Area
Industry:
Medical Practice
Work:
The National Retina Institute
-
Owner
Dr. Bert M Glaser, Columbia MD - MD (Doctor of Medicine)
Dr. Bert M Glaser, Columbia MD - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
PHYSICIANS EYE CARE CTR LLC
11055 Little Patuxent Pkwy SUITE 105, Columbia 21044
(410) 964-8285 (Phone), (410) 964-9414 (Fax)
National Retina Institute
901 Dulaney Valley Rd SUITE 200, Towson 21204
(410) 337-4500 (Phone)
11055 Little Patuxent Pkwy SUITE 105, Columbia 21044
(410) 964-8285 (Phone), (410) 964-9414 (Fax)
National Retina Institute
901 Dulaney Valley Rd SUITE 200, Towson 21204
(410) 337-4500 (Phone)
Certifications:
Ophthalmology, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
PHYSICIANS EYE CARE CTR LLC
11055 Little Patuxent Pkwy SUITE 105, Columbia 21044
National Retina Institute
901 Dulaney Valley Rd SUITE 200, Towson 21204
Greater Baltimore Medical Center
6701 North Charles Street Ave, Towson 21204
Inova Fairfax Hospital
3300 Gallows Rd, Falls Church 22042
Sinai Hospital of Baltimore
2401 West Belvedere Ave, Baltimore 21215
Suburban Hospital
8600 Old Georgetown Rd, Bethesda 20814
11055 Little Patuxent Pkwy SUITE 105, Columbia 21044
National Retina Institute
901 Dulaney Valley Rd SUITE 200, Towson 21204
Greater Baltimore Medical Center
6701 North Charles Street Ave, Towson 21204
Inova Fairfax Hospital
3300 Gallows Rd, Falls Church 22042
Sinai Hospital of Baltimore
2401 West Belvedere Ave, Baltimore 21215
Suburban Hospital
8600 Old Georgetown Rd, Bethesda 20814
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1976
The Johns Hopkins Hospital
Columbia University / College of Physicians And Surgeons
Graduated: 1976
The Johns Hopkins Hospital
Ceo At The National Retina Institute
Ceo At The National Retina Institute
Position:
CEO at The National Retina Institute
Location:
Baltimore, Maryland Area
Industry:
Medical Practice
Work:
The National Retina Institute
-
CEO
Skills:
Clinical Research, Healthcare
System And Method For Identifying Biomarkers In Ocular Fluid That Are Indicative Of Ocular Disease
System And Method For Identifying Biomarkers In Ocular Fluid That Are Indicative Of Ocular Disease
US Patent:
2010015, Jun 17, 2010
Filed:
Dec 4, 2009
Appl. No.:
12/631800
Inventors:
Bert Glaser - Towson MD, US
International Classification:
A61K 39/395, C40B 30/04
US Classification:
4241331, 506 9
Abstract:
A system and method for testing ocular fluid, such as vitreous fluid. The testing can be used to both determine if an ocular disease is present and to quantify the effectiveness of a treatment for that ocular disease. A sample of ocular fluid is drawn from a patient and tested for the presence of targeted biomarkers and for the level of those biomarkers. The level of the biomarkers in the patients sample is compared to the normal range. If the level of the targeted biomarker falls outside the normal range, an abnormal condition is recognized. The effectiveness of any treatment can be analyzed by repeating the testing process. After a treatment, ocular fluid is again drawn. The biomarker levels can be identified and compared to those taken before treatment began. If the level of the targeted biomarkers trends toward normal, the treatment is known to be effective.
Method Of Treating Ophthalmic Disorders Using Tgf -.Beta.
Method Of Treating Ophthalmic Disorders Using Tgf -.Beta.
US Patent:
5767079, Jun 16, 1998
Filed:
Aug 27, 1996
Appl. No.:
8/705694
Inventors:
Bert M. Glaser - Baltimore MD
Bruce B. Pharriss - late of Palo Alto CA
Ann F. Hanham - Palo Alto CA
George A. Ksander - Redwood City CA
Bruce B. Pharriss - late of Palo Alto CA
Ann F. Hanham - Palo Alto CA
George A. Ksander - Redwood City CA
Assignee:
Celtrix Pharmaceuticals, Inc. - Santa Clara CA
International Classification:
A61K 3818
US Classification:
514 12
Abstract:
This invention is a method for the treatment of ophthalmic disorders. The method is suitable for treatment of a variety of disorders including macular holes, macular degeneration, and retinal detachment and tears, cataracts, and corneal and scleral injuries. The method entails application of an effective amount of Transforming Growth Factor-. beta. (TGF-. beta. ) to the affected region.
Sampling Ocular Fluid
Sampling Ocular Fluid
US Patent:
2009031, Dec 24, 2009
Filed:
Dec 17, 2008
Appl. No.:
12/337602
Inventors:
Bert M. Glaser - Baltimore MD, US
International Classification:
A61M 1/00
US Classification:
604 35
Abstract:
The present invention includes an ophthalmic aspirating device that allows the relatively non-invasive removal of small volumes of ocular fluid for diagnostic and other purposes. The invention also includes an ophthalmic aspirating device that allows the for the injection of materials into the eye at the time of aspiration. The invention further includes methods of aspirating ocular fluid from an eye using an ophthalmic aspirating device.
Internal Limiting Membrane Rake
Internal Limiting Membrane Rake
US Patent:
7731728, Jun 8, 2010
Filed:
Apr 14, 2005
Appl. No.:
11/105342
Inventors:
Bert M. Glaser - Towson MD, US
International Classification:
A61B 17/24, A61F 9/00, A61F 11/00
US Classification:
606161
Abstract:
A medical device for removing a thin membrane from the inner surface of an eye. The device comprises a rake that includes a handle having a hollow body from which a slide member telescopes. A plurality of tines are provided on a free end of the slide member, wherein each tine includes a tissue engaging feature provided on a free end of each tine. The tines are extended and retracted from an end of the handle, such that, when completely retracted, only the tissue engaging features protrude from the handle or all tissue engaging features can be retracted into the handle. In operation, the rake is manipulated along an upper surface of the membrane until the tissue engaging features engage the membrane. Once the tines engage the membrane, the rake is moved upward and tangentially away relative to an upper surface of the retina until the membrane is removed therefrom.